Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Lambrey

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Arthritis and Rheumatism|February 1, 1986
Destructive spondylarthropathy in hemodialyzed patients: possible role of amyloidosisJ L Sebert, P Fardellone, A Marie, et al.
La Nouvelle Presse Medicale|November 12, 1977
[Renal osteodystrophy-II-Recent therapeutic acquisitions (author's transl)]J L Sebert, A E Fournier, J Gueris, et al.
Proceedings of the European Dialysis and Transplant Association - European Renal Association. European Dialysis and Transplant Association - European Renal Association. Congress|January 1, 1985
Influence of biochemical and hormonal factors on the bone histomorphometric features of uraemic patientsA Fournier, J L Sebert, P Fohrer, et al.
Annales De Medecine Interne|January 1, 1990
[Epidemiology of primary glomerulonephritis in Picardie]Z Abdulmassih, R Makdassi, N Bove, et al.
Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association|January 1, 1979
Limitation by hyperphosphataemia of the "prophylactic" use of vitamin D metabolites in the treatment of osteitis fibrosa in patients on chronic haemodialysisJ F de Fremont, J L Sebert, J Gueris, et al.
Proceedings of the European Dialysis and Transplant Association - European Renal Association. European Dialysis and Transplant Association - European Renal Association. Congress|January 1, 1985
The desferrioxamine test predicts bone aluminium burden induced by A1(OH)3 in uraemic patients but not mild histological osteomalaciaA Fournier, P Fohrer, P Leflon, et al.
Revue Du Rhumatisme Et Des Maladies Osteo-Articulaires|July 1, 1986
[Destructive spondylarthropathy with amyloid deposits in 3 patients on chronic hemodialysis]J L Sébert, P Fardellone, H Deramond, et al.
Kidney International|August 5, 1999
Critical evaluation of plasma and LDL oxidant-trapping potential in hemodialysis patientsT Nguyen-Khoa, Z A Massy, V Witko-Sarsat, et al.
Nephrologie|January 1, 1980
[Evidence, in uremic man, of the role of beta 2 adrenergic receptors in the secretion of parathyroid hormone and calcitonin (author's transl)]B Coevoet, G Lambrey, J F de Frémont, et al.
Clinical Nephrology|November 1, 1979
Effects of antihypertensive drugs on dialysis-resistant hypertension, plasma renin and dopamine betahydroxylase activities, metabolic risk factors and calcium phosphate homeostasis: comparison of metoprolol, alphamethyldopa and clonidine in a cross-over trialJ F de Fremont, B Coevoet, M Andrejak, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Arthritis and Rheumatism|February 1, 1986
Destructive spondylarthropathy in hemodialyzed patients: possible role of amyloidosisJ L Sebert, P Fardellone, A Marie, et al.
La Nouvelle Presse Medicale|November 12, 1977
[Renal osteodystrophy-II-Recent therapeutic acquisitions (author's transl)]J L Sebert, A E Fournier, J Gueris, et al.
Proceedings of the European Dialysis and Transplant Association - European Renal Association. European Dialysis and Transplant Association - European Renal Association. Congress|January 1, 1985
Influence of biochemical and hormonal factors on the bone histomorphometric features of uraemic patientsA Fournier, J L Sebert, P Fohrer, et al.
Annales De Medecine Interne|January 1, 1990
[Epidemiology of primary glomerulonephritis in Picardie]Z Abdulmassih, R Makdassi, N Bove, et al.
Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association|January 1, 1979
Limitation by hyperphosphataemia of the "prophylactic" use of vitamin D metabolites in the treatment of osteitis fibrosa in patients on chronic haemodialysisJ F de Fremont, J L Sebert, J Gueris, et al.
Proceedings of the European Dialysis and Transplant Association - European Renal Association. European Dialysis and Transplant Association - European Renal Association. Congress|January 1, 1985
The desferrioxamine test predicts bone aluminium burden induced by A1(OH)3 in uraemic patients but not mild histological osteomalaciaA Fournier, P Fohrer, P Leflon, et al.
Revue Du Rhumatisme Et Des Maladies Osteo-Articulaires|July 1, 1986
[Destructive spondylarthropathy with amyloid deposits in 3 patients on chronic hemodialysis]J L Sébert, P Fardellone, H Deramond, et al.
Kidney International|August 5, 1999
Critical evaluation of plasma and LDL oxidant-trapping potential in hemodialysis patientsT Nguyen-Khoa, Z A Massy, V Witko-Sarsat, et al.
Nephrologie|January 1, 1980
[Evidence, in uremic man, of the role of beta 2 adrenergic receptors in the secretion of parathyroid hormone and calcitonin (author's transl)]B Coevoet, G Lambrey, J F de Frémont, et al.
Clinical Nephrology|November 1, 1979
Effects of antihypertensive drugs on dialysis-resistant hypertension, plasma renin and dopamine betahydroxylase activities, metabolic risk factors and calcium phosphate homeostasis: comparison of metoprolol, alphamethyldopa and clonidine in a cross-over trialJ F de Fremont, B Coevoet, M Andrejak, et al.
Pageof 4